Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| 4arm-PEG10K-Maleimide | average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). |  |
| 4arm-PEG10K-Maleimide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-MAL, 4arm-PEG-Maleimide. Molecular formula: average Mn 10000. |  |
| 4arm-PEG20K-Maleimide | average Mn 20,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG20K-Maleimide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-MAL, 4arm-PEG-Maleimide. Molecular formula: average Mn 20000. | |
| 4arm-PEG40K-Maleimide | average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 4arm-PEG40K-Maleimide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-MAL, 4arm-PEG-Maleimide. Molecular formula: average Mn 40000. | |
| 5'-(3-MAL-PEG2-aminobutanoate)-floxuridine | A derivative of Floxuridine. Floxuridine is a prodrug that is rapidly catabolized in vivo to 5-fluorouracil when administered by rapid injection. Synonyms: 5'-(3-MAL-PEG2-aminobutanoate)-floxuridine. Grades: > 95%. Molecular formula: C29H42FN5O13. Mole weight: 687.68. |  |
| 8arm-PEG10K-Maleimide | 8arm-PEG10K-Maleimide. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-Maleimide | hexaglycerol core, average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG10K-Maleimide | tripentaerythritol core, average Mn 10,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG20K-Maleimide | 8arm-PEG20K-Maleimide. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG20K-Maleimide | hexaglycerol core, average Mn 20,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG20K-Maleimide | tripentaerythritol core, average Mn 20,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG40K-Maleimide | hexaglycerol core, average Mn 40,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG40K-Maleimide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-Maleimide. Molecular formula: average Mn 40000. | |
| Alkyne-PEG3500-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| Alkyne-PEG4-maleimide | Alkyne-PEG4-maleimide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs [1]. Alkyne-PEG4-maleimide is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. Uses: Scientific research. Group: Signaling pathways. CAS No. 1609651-90-2. Pack Sizes: 100 mg. Product ID: HY-133399. |  |
| Cholesterol-PEG-MAL (MW 2000) | Cholesterol-PEG-MAL (MW 2000) is a PEG derivative and can be used to prepare liposome or nanoparticle due to its ability to self-assemble in water. The maleimide moiety is reactive with thiol molecule to form a covalent thioether bond. Uses: Scientific research. Group: Signaling pathways. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-W440719. | |
| DBCO-PEG4-Maleimide | DBCO-PEG4-Maleimide is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) [1]. DBCO-PEG4-Maleimide is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. Uses: Scientific research. Group: Signaling pathways. CAS No. 1480516-75-3. Pack Sizes: 25 mg. Product ID: HY-120770. | |
| DMG-PEG-Mal (MW 2000) | DMG-PEG-Mal (MW 2000) is a PEG lipid that can improve the delivery efficiency and tissue specificity of poorly soluble drugs. DMG-PEG-Mal (MW 2000) can be used in drug delivery research[1]. Uses: Scientific research. Group: Biochemical assay reagents. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-167036. | |
| DSPE-PEG2000-Mal ammonium | DSPE-PEG-Maleimide has DSPE phospholipid and maleimide to prepare nanostructured lipid carrier. DSPE-PEG-Maleimide extends blood circulation time and higher stability for encapsulated agents [1] [2]. Uses: Scientific research. Group: Biochemical assay reagents. Alternative Names: DSPE-PEG2000 Maleimide ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] ammonium. CAS No. 474922-22-0. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-144004. | |
| DSPE-PEG2000-Maleimide | DSPE-PEG2000-Maleimide is a phospholipid-PEG conjugate. DSPE-PEG2000-Maleimide utilizes the amphiphilicity of DSPE to insert into the lipid bilayer of liposomes or nanoparticles. DSPE-PEG2000-Maleimide covalently couples to the sulfhydryl (-SH) of ligands (such as antibodies, peptides, or proteins) via thiol-maleimide click chemistry, giving the particles targeting capabilities. DSPE-PEG2000-Maleimide can be used in the researches of breast cancer, lymphoma, and inherited retinal degeneration[1][2][3][4]. Uses: Scientific research. Group: Biochemical assay reagents. Pack Sizes: 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-140739. | |
| DSPE-PEG5000-Mal ammonium | DSPE-PEG-Maleimide has DSPE phospholipid and maleimide to prepare nanostructured lipid carrier. DSPE-PEG-Maleimide extends blood circulation time and higher stability for encapsulated agents [1] [2]. DSPE-PEG5000-Mal ammonium contains PEG5000. Uses: Scientific research. Group: Biochemical assay reagents. Alternative Names: DSPE-PEG5000 Maleimide ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-5000] ammonium. CAS No. 474922-22-0. Pack Sizes: 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-144004A. | |
| DSPE-PEG(5000) Maleimide | DSPE-PEG(5000) Maleimide. Group: Others. Purity: >99%. Mole weight: 5937.179 (average MW due to polydispersity of PEG). Stability: 6 Months. Storage: -20°C. DSPE-PEG(5000) Maleimide; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-5000] (ammonium salt) ; Polymers; Polymerizable Lipids; lipid products; lipid. Cat No: PCNZ-004. |  |
| DSPE-PEG-Maleimide (MW 2000) | DSPE-PEG-Maleimide (MW 2000) is a phospholipid. Phospholipids have good biocompatibility and significant amphiphilic characteristics, making them the main and suitable dosage form or excipient in drug formulations, thereby achieving better therapeutic effects. DSPE-PEG-Maleimide (MW 2000)can be used in drug delivery research[1]. Uses: Scientific research. Group: Biochemical assay reagents. Pack Sizes: 25 mg; 50 mg; 100 mg. Product ID: HY-166648. | |
| DSPE-PEG-Maleimide, MW 5000 | DSPE-PEG-Maleimide, MW 5000 has DSPE phospholipid and maleimide to prepare nanostructured lipid carrier. DSPE-PEG-maleimide extends blood circulation time and higher stability for encapsulated agents[1][2]. Uses: Scientific research. Group: Biochemical assay reagents. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 500 mg. Product ID: HY-140740. | |
| endo-BCN-PEG3-mal | endo-BCN-PEG3-mal is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. endo-BCN-PEG3-mal is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. Uses: Scientific research. Group: Signaling pathways. CAS No. 2141976-33-0. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-133400. | |
| Mal-amide-PEG8-Val-Ala-PAB-PNP | Mal-amide-PEG8-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2210247-59-7. Pack Sizes: 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-148425. | |
| Mal-amido-PEG9-amine TFA | Mal-amido-PEG9-amine (TFA) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2569576-12-9. Pack Sizes: 5 mg; 10 mg. Product ID: HY-140976A. | |
| Maleimide-PEG4-NHS | This molecular is a sulfhydryl and amine reactive heterofuncational PEG linker. The chemical bonds that formed through Maleimide-PEG4-NHS linker are very stable. The NHS ester reacts with amino groups at pH 7-9 to form stable amide bond. In addiction, the maleimide reacts with thiol groups at pH 6.5-7.5 to form stable thiol-ether bond. Maleimide-PEG4-NHS is a very useful linker for various biomolecule crosslinking applications (such as to make ADCs (antibody drug conjugates.)). Uses: Useful linker for various biomolecule crosslinking applications. Synonyms: Maleimide-PEG4-NHS; MAL-PEG4-NHS; Maleimide PEG NHS; MAL-PEG-NHS; Maleimido-Tetra(Ethylene Glycol)?-Acetic Acid NHS ester;2,5-dioxopyrrolidin-1-yl 14-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3,6,9,12-tetraoxatetradecanoate. Grades: 98%. CAS No. 1286754-10-6. Molecular formula: C18H24N2O10. Mole weight: 428.39. | |
| Maleimide-PEG5K-OH | average Mn 5,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| Maleimide-PEG5K-OH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: MAL-PEG-OH, Maleimide, Maleimide-PEG-OH. Molecular formula: average Mn 5000. | |
| Maleimide-PEG-b-PLGA | Maleimide-PEG-b-PLGA. Synonyms: Maleimide poly(ethylene glycol)-block-poly(lactide-co-glycolide). Product ID: MSMN-048. Category: Raw Materials. |  |
| Mal-NH-PEG12-acid | Mal-NH-PEG12-acid. Uses: Designed for use in research and industrial production. Product Category: Acid PEG Linkers. CAS No. 871133-36-7. Molecular formula: C34H60N2O17. Mole weight: 768.39. Purity: 95%+. Product ID: ACM871133367. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Mal-NH-PEG4-acid | Mal-NH-PEG4-acid. Uses: Designed for use in research and industrial production. Product Category: Acid PEG Linkers. CAS No. 1263045-16-4. Molecular formula: C18H28N2O9. Mole weight: 416.18. Purity: 95%+. Product ID: ACM1263045164. Alfa Chemistry ISO 9001:2015 Certified. | |
| Mal-NH-PEG4-NHS ester | Mal-NH-PEG4-NHS ester. Uses: Designed for use in research and industrial production. Product Category: Other PEG Linkers. CAS No. 756525-99-2. Molecular formula: C22H31N3O11. Mole weight: 513.2. Purity: 95%+. Product ID: ACM756525992-1. Alfa Chemistry ISO 9001:2015 Certified. Categories: 1-Maleinimido-3-oxo-7,10,13,16-tetraoxa-4-azanonadecan-19-oic acid succinimidyl ester. | |
| Mal-NH-PEG8-NHS ester | Mal-NH-PEG8-NHS ester. Uses: Designed for use in research and industrial production. Product Category: Other PEG Linkers. CAS No. 756525-93-6. Molecular formula: C30H47N3O15. Mole weight: 689.71. Purity: 95%+. Product ID: ACM756525936. Alfa Chemistry ISO 9001:2015 Certified. | |
| Mal-PEG12-NHS ester | Mal-PEG12-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2669737-09-9. Pack Sizes: 5 mg; 10 mg. Product ID: HY-140963. | |
| Mal-PEG1-NHS ester | Mal-PEG1-NHS ester. Uses: Designed for use in research and industrial production. Product Category: Other PEG Linkers. CAS No. 1807518-72-4. Molecular formula: C13H14N2O7. Mole weight: 310.26. Purity: 95%+. Product ID: ACM1807518724. Alfa Chemistry ISO 9001:2015 Certified. | |
| MAL-PEG2000-B-PLA2000 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| MAL-PEG2000-NH2TFA | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 2000. ≥95%. | |
| Mal-PEG24-NHS ester | Mal-PEG24-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2226733-37-3. Pack Sizes: 5 mg; 10 mg. Product ID: HY-135819. | |
| Mal-PEG2-acid | Mal-PEG2-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG2-acid can be conjugated to Tubulysin (HY-128914) and its derivative cytotoxic molecule [1]. Mal-PEG2-acid is also a PROTAC linker that can be used in the synthesis of PROTACs. Uses: Scientific research. Group: Signaling pathways. CAS No. 1374666-32-6. Pack Sizes: 25 mg; 50 mg; 100 mg; 250 mg. Product ID: HY-130442. | |
| Mal-PEG2-acid | Mal-PEG2-acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Uses: Designed for use in research and industrial production. Additional or Alternative Names: Mal-PEG2-CH2CH2COOH. Product Category: Other PEG Linkers. Appearance: Liquid. CAS No. 1374666-32-6. Molecular formula: C11H15NO6. Mole weight: 257.24. Purity: >90%. IUPACName: 3-[2-[2-(2,5-Dioxopyrrol-1-yl)ethoxy]ethoxy]propanoic acid. Canonical SMILES: C1=CC(=O)N(C1=O)CCOCCOCCC(=O)O. Density: 1.3±0.1 g/cm3. Product ID: ACM1374666326. Alfa Chemistry ISO 9001:2015 Certified. | |
| Mal-PEG2-NH2 TFA | Mal-PEG2-NH2 (TFA) is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 660843-23-2. Pack Sizes: 50 mg; 100 mg. Product ID: HY-35261A. | |
| Mal-PEG2-NHS | Mal-PEG2-NHS is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 329364-72-9. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-138430. | |
| Mal-PEG2-NHS ester | Mal-PEG2-NHS ester is a nonclaevable ADC linker containing a Maleimide group, 2-unit PEG and an NHS ester. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 2,5-Dioxopyrrolidin-1-yl 3-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)propanoate. Product Category: Azido PEG Linkers. Appearance: Liquid. CAS No. 1433997-01-3. Molecular formula: C15H18N2O8. Mole weight: 354.31. Purity: >90%. IUPACName: (2,5-Dioxopyrrolidin-1-yl) 3-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]propanoate. Canonical SMILES: C1CC(=O)N(C1=O)OC(=O)CCOCCOCCN2C(=O)C=CC2=O. Density: 1.4±0.1 g/cm3. Product ID: ACM1433997013. Alfa Chemistry ISO 9001:2015 Certified. | |
| Mal-PEG2-NHS ester | Mal-PEG2-NHS ester is a nonclaevable ADC linker containing a Maleimide group, 2-unit PEG and an NHS ester. Uses: Scientific research. Group: Signaling pathways. CAS No. 1433997-01-3. Pack Sizes: 50 mg; 100 mg; 250 mg; 1 g; 5 g. Product ID: HY-126504. | |
| Mal-PEG2-Val-Cit-PABA-PNP | Mal-PEG2-Val-Cit-PABA-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1345681-52-8. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-131156. | |
| Mal-PEG2-Val-Cit-PAB-OH | Mal-PEG2-Val-Cit-PAB-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Mal-PEG2-Val-Cit-PAB-OH also can be used as a PROTAC linker that can be used in the synthesis of PROTACs. Uses: Scientific research. Group: Signaling pathways. CAS No. 2055041-38-6. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-130222. | |
| Mal-PEG3-NH2 TFA | Mal-PEG3-NH2 TFA is a linear heterobifunctional PEG crosslinker with Maleimide (HY-W007324) and amine. Mal-PEG3-NH2 TFA is a non-degradable (non-cleavable) PROTAC linker[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2830214-77-0. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-W190796A. | |
| Mal-PEG4 | Mal-PEG4. Uses: Designed for use in research and industrial production. Product Category: Other PEG Linkers. CAS No. 1421933-37-0. Molecular formula: C13H20NO6. Mole weight: 273.28. Purity: 95%+. Product ID: ACM1421933370. Alfa Chemistry ISO 9001:2015 Certified. | |
| Mal-?PEG4-?NHS ester | Mal-PEG4-NHS ester is a non-cleavable ADC linker which links Quantum dots (QDs) with PEGylated liposomes [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1325208-25-0. Pack Sizes: 50 mg; 100 mg; 250 mg. Product ID: HY-126505. | |
| Mal-PEG4-NHS ester | Mal-PEG4-NHS ester is a nonclaevable ADC linker containing a Maleimide group, 4-unit PEG and an NHS ester. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4,7,10,13-Tetraoxapentadecanoic acid, 15-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-, 2,5-dioxo-1-pyrrolidinyl ester. Product Category: Other PEG Linkers. Appearance: Liquid. CAS No. 1325208-25-0. Molecular formula: C19H26N2O10. Mole weight: 442.4. Purity: >90%. IUPACName: (2,5-Dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]ethoxy]ethoxy]propanoate. Canonical SMILES: C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCOCCN2C(=O)C=CC2=O. Density: 1.4±0.1 g/cm3. Product ID: ACM1325208250. Alfa Chemistry ISO 9001:2015 Certified. | |
| Mal-PEG4-VA-PBD | Mal-PEG4-VA-PBD is a agent-linker conjugate for ADC by using the antitumor antibiotic, Pyrrolobenzodiazepine (PBD), linked via Mal-PEG4-VA. Uses: Scientific research. Group: Signaling pathways. CAS No. 1342820-68-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-126685. | |
| Mal-PEG4-VC-PAB-DMEA-PNU-159682 | Mal-PEG4-VC-PAB-DMEA-PNU-159682, a agent-linker conjugate for ADC, consists the ADC linker Mal-PEG4-VC-PAB and a potent ADC cytotoxin DMEA-PNU-159682. DMEA-PNU-159682 includes metabolites of nemorubicin (MMDX) from liver microsomes and ADC cytotoxin PNU-159682[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2259318-52-8. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg. Product ID: HY-126687. | |
| Mal-PEG5-acid | Mal-PEG5-acid. Uses: Designed for use in research and industrial production. Product Category: Acid PEG Linkers. CAS No. 518044-41-2. Molecular formula: C15H23NO8. Mole weight: 345.35. Purity: 95%+. Product ID: ACM518044412. Alfa Chemistry ISO 9001:2015 Certified. | |
| Mal-PEG5-PFP ester | Mal-PEG5-PFP ester. Uses: Designed for use in research and industrial production. Product Category: Other PEG Linkers. CAS No. 1415800-42-8. Molecular formula: C21H22F5NO8. Mole weight: 511.39. Purity: 95%+. Product ID: ACM1415800428. Alfa Chemistry ISO 9001:2015 Certified. | |
| Mal-PEG5-t-butyl ester | Mal-PEG5-t-butyl ester. Uses: Designed for use in research and industrial production. Product Category: t-butyl Ester PEG Linkers. CAS No. 518044-36-5. Molecular formula: C19H31NO8. Mole weight: 401.45. Purity: 95%+. Product ID: ACM518044365. Alfa Chemistry ISO 9001:2015 Certified. | |
| Mal-PEG6-NHS ester | Mal-PEG6-NHS ester is a nonclaevable ADC linker containing a Maleimide group, 6-unit PEG and a NHS ester. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 2,5-Dioxopyrrolidin-1-yl 1-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-3,6,9,12,15,18-hexaoxahenicosan-21-oate. Product Category: Other PEG Linkers. Appearance: Liquid. CAS No. 1599472-25-9. Molecular formula: C23H34N2O12. Mole weight: 530.5. Purity: >90%. IUPACName: (2,5-Dioxopyrrolidin-1-yl) 3-[2-[2-[2-[2-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoate. Canonical SMILES: C1CC(=O)N(C1=O)OC(=O)CCOCCOCCOCCOCCOCCOCCN2C(=O)C=CC2=O. Density: 1.3±0.1 g/cm3. Product ID: ACM1599472259. Alfa Chemistry ISO 9001:2015 Certified. | |
| Mal-PEG7-acid | Mal-PEG7-acid. Uses: Designed for use in research and industrial production. Product Category: Acid PEG Linkers. CAS No. 518044-42-3. Molecular formula: C19H31NO10. Mole weight: 433.45. Purity: 95%+. Product ID: ACM518044423. Alfa Chemistry ISO 9001:2015 Certified. Categories: Mal-PEG6-Acid. | |
| Mal-PEG8-acid | Mal-PEG8-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Uses: Scientific research. Group: Signaling pathways. CAS No. 1818294-46-0. Pack Sizes: 25 mg; 50 mg; 100 mg. Product ID: HY-130334. | |
| Mal-PEG8-NHS ester | Mal-PEG8-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Uses: Scientific research. Group: Signaling pathways. CAS No. 2055033-05-9. Pack Sizes: 25 mg; 50 mg; 100 mg; 250 mg; 1 g. Product ID: HY-126887. | |
| Mal-PEG8-NHS ester | Mal-PEG8-NHS ester. Uses: Designed for use in research and industrial production. Product Category: NHS Ester PEG Linkers. CAS No. 2055033-05-9. Molecular formula: C27H42N2O14. Mole weight: 618.26. Purity: 95%+. Product ID: ACM2055033059. Alfa Chemistry ISO 9001:2015 Certified. | |
| Mal-PEG8-Val-Ala-PAB-Exatecan | Mal-PEG8-Val-Ala-PAB-Exatecan (Compound 9b) is an antibody-drug conjugate linker (ADC linker) that binds to Nectin-4 polypeptides conjugated to chemotherapeutic agents. Mal-PEG8-Val-Ala-PAB-Exatecan can be used for cancer research[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2679821-39-5. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-147271. | |
| Mal-PEG8-Val-Cit-PAB-MMAE | Mal-PEG8-Val-Cit-PAB-MMAE is a agent-linker conjugate for ADC. Mal-PEG8-Val-Cit-PAB-MMAE contains a cleavable ADC linker and a potent tubulin inhibitor MMAE (HY-15162)[1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2353409-69-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-141156. | |
| Methyltetrazine-PEG4-maleimide | Methyltetrazine-PEG4-maleimide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs [1]. Methyltetrazine-PEG4-maleimide is a click chemistry reagent, it contains a Tetrazine group that can undergo an inverse electron demand Diels-Alder reaction (iEDDA) with molecules containing TCO groups. Uses: Scientific research. Group: Signaling pathways. CAS No. 1802908-02-6. Pack Sizes: 5 mg; 10 mg; 25 mg. Product ID: HY-141278. | |
| mPEG20K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-MAL, Methoxy-PEG-Maleimide. Molecular formula: average Mn 20000. | |
| mPEG2K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-MAL, Methoxy-PEG-Maleimide. Molecular formula: average Mn 2000. | |
| mPEG40K-MAL | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-MAL, Methoxy-PEG-Maleimide. Molecular formula: average Mn 40000. | |
Our database is helping our users find suppliers everyday.
